More research is needed to evaluate the long-term effects of biological therapy and to conduct double-blind, standardized trials comparing anti-IL-4, anti-IgE, and anti-IL-5 therapies for CRSwNP patients. This evidence concerns the gene IL5 and chronic rhinosinusitis with nasal polyps.